Publications by authors named "Masashi Nakamatsu"

Rationale: Although the mortality of severe coronavirus disease 2019 (COVID-19) has decreased after the emergence of the Omicron variant, it remains high in patients on hemodialysis (HD). Remdesivir (RDV) is considered as the first line drug for hospitalized COVID-19 patients, however the evidence regarding the usage in HD patients is lacking because clinical trials of RDV have excluded HD patients for safety reasons. Thus, accumulation of knowledge on the regimen, efficacy, and tolerability of RDV in HD patients is important.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined the clinical characteristics and risk factors associated with severe COVID-19 cases caused by the XBB variant in Okinawa, Japan, during mid-2023.
  • - Out of 367 hospitalized patients, 18.5% were classified as severe, with older age and underlying health conditions linked to a higher mortality rate (13.2% in severe cases vs. 3.0% in mild cases).
  • - Notably, diabetes mellitus increased the risk for severe COVID-19, while receiving the bivalent omicron booster significantly reduced the severity of the disease.
View Article and Find Full Text PDF

is highly virulent but often misidentified in clinical settings. The entire genome sequence of a metallo-β-lactamase-producing strain from a clinical specimen has been presented in this study. The genome comprised a single chromosome of 4.

View Article and Find Full Text PDF

Background: Infective endocarditis (IE) caused by MRSA (methicillin-resistant Staphylococcus aureus) is associated with a high mortality rate. This study aimed to elucidate the characteristics of patients with MRSA-IE in Japan and identify the factors associated with prognosis.

Methods: This retrospective study included patients with a confirmed diagnosis of IE caused by MRSA, between January 2015 and April 2019.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated how seasonal influenza affects adults with invasive pneumococcal disease (IPD) in Japan, analyzing data from 1722 patients before and during the COVID-19 pandemic.
  • It found that the seasonal influenza epidemic declined with the pandemic, and there was a notable decrease in bacteremic pneumonia cases during this time.
  • Additionally, patients with a history of seasonal influenza had a higher rate of bacteremic pneumonia and a greater risk of death, especially among older males, prior to the pandemic.
View Article and Find Full Text PDF
Article Synopsis
  • MRSA infective endocarditis (IE) has a high risk of complications and death, prompting a study to analyze patient data from Japan focusing on treatment and outcomes.
  • The study involved 64 patients with MRSA-IE, revealing a high mortality rate of 28.1% at 30 days and 45.3% during hospitalization, with glycopeptides being the most commonly used initial treatment.
  • While the choice of antibiotic therapy (glycopeptide, daptomycin, linezolid) did not significantly affect prognosis, further research is needed to identify the best first-line treatments for MRSA-IE.
View Article and Find Full Text PDF

Nucleic acid amplification test (NAAT) is the gold standard for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. However, genetic mutations in the virus can affect the result. Cycle threshold (Ct) values of N genes and their association with mutations using SARS-CoV-2 positive specimens diagnosed by the Xpert Xpress SARS-CoV-2 were examined in this study.

View Article and Find Full Text PDF

Streptococcus agalactiae (Group B Streptococcus, GBS) is an invasive pathogen that causes sepsis and meningitis among infants, elderly adults, and immunosuppressed patients. Generally, GBS is susceptible to penicillin; however, GBS with reduced penicillin susceptibility (PRGBS) has been reported. PRGBS are commonly isolated from respiratory specimens, but clinical features of patients with PRGBS remain unclear.

View Article and Find Full Text PDF

Background: In Japan, the national action plan to adress antimicrobial resistance problems aimed to reduce the use of oral cephalosporins, quinolones, and macrolides per day per 1000 inhabitants by 50% from the levelin 2013 by 2020. The aim of this study was to evaluate the effects of a revised antibiotic formulary on in- and out-hospital oral antibiotic prescribing practices at a 600-bed university hospital.

Method: A retrospective before-and-after comparison study was conducted.

View Article and Find Full Text PDF

The case is presented of a 29-year-old primiparous woman who was COVID-19-positive at 34 weeks of gestation and who developed severe acute respiratory distress syndrome. After a four-day history of fever and mild dyspnea, she was referred to hospital. Ciclesonide, dexamethasone, heparin sodium, and sulbactam/ampicillin were initiated, followed by remdesivir and tocilizumab.

View Article and Find Full Text PDF

The COVID-19 pandemic has caused serious health and social concerns worldwide. Although the primary target of SARS-CoV-2 is the respiratory tract, SARS-CoV-2 infection also causes extrapulmonary symptoms. Previous articles have reported ischemic colitis in COVID-19 patients; however, information regarding its clinical manifestations and pathophysiology is limited.

View Article and Find Full Text PDF

Anticoagulation plays a major role in reducing the risk of systematic thrombosis in patients with severe COVID-19. Serious hemorrhagic complications, such as intracranial hemorrhage, have also been recognized. However, intra-abdominal hemorrhage is under-recognized because of its rare occurrence, despite high mortality.

View Article and Find Full Text PDF
Article Synopsis
  • Tocilizumab (TCZ) is used to reduce cytokine release syndrome (CRS) in COVID-19 patients by blocking interleukin-6 (IL-6) signalling, but its side effects are not fully understood.
  • A 45-year-old patient with COVID-19 developed acute hypertriglyceridaemia after receiving TCZ, despite being treated with favipiravir for respiratory issues.
  • Medical professionals should be cautious of TCZ's potential negative effects on lipid levels in COVID-19 patients, which could be compounded by the impact of the disease itself on lipids.
View Article and Find Full Text PDF
Article Synopsis
  • The mcr-1 gene helps bacteria resist colistin, an antibiotic, by adding phosphoethanolamine to a part of their cell membrane called lipid A.
  • A specific 33-kb plasmid containing the mcr-1 gene was found in Klebsiella pneumoniae and Escherichia coli bacteria in hospitals in Okinawa, Japan.
  • Additionally, a larger 66-kb plasmid was also identified in three E. coli isolates from the same hospitals, indicating the spread of resistance genes among different bacterial strains.
View Article and Find Full Text PDF

The mcr-1 is a gene encoding a phosphoethanolamine transferase, which confers resistance to colistin by transferring phosphoethanolamine to lipid A. We describe here the emergence of a colistin-resistant Escherichia coli clinical isolate harboring plasmid-mediated mcr-1 in Japan. The isolate belonged to ST5702 and is suspected to come from livestock and transmitted to human.

View Article and Find Full Text PDF

Although many reports have already shown RSV outbreaks among hemato-oncology patients, genomic studies detecting similar RSV strains prior to an outbreak in the hospital are rare. In 2014, the University of the Ryukyus hospital hemato-oncology unit experienced, and successfully managed, a respiratory syncytial virus (RSV) nosocomial outbreak. During the outbreak investigation, genotyping and phylogenetic analysis was used to identify a potential source for the outbreak.

View Article and Find Full Text PDF

Teicoplanin, a glycopeptide antibiotic for methicillin-resistant Staphylococcus aureus, is recommended for therapeutic drug monitoring during treatment. Maintaining a high trough range of teicoplanin is also recommended for severe infectious disease. However, the optimal dose and interval of treatment for severe renal impairment is unknown.

View Article and Find Full Text PDF

Previously, we demonstrated that Valpha14+ NKT cells and IFN-gamma are important upstream components in neutrophil-mediated host defense against infection with Streptococcus pneumoniae. In the present study, we extended these findings by elucidating the role of IFN-gamma in this Valpha14+ NKT cell-promoted process. Administration of recombinant IFN-gamma to Jalpha18KO mice prolonged the shortened survival, promoted the attenuated clearance of bacteria and improved the reduced accumulation of neutrophils and synthesis of MIP-2 and TNF-alpha in the lungs, in comparison to wild-type (WT) mice.

View Article and Find Full Text PDF

The present study was designed to elucidate the role of Vgamma4(+) gammadelta T cells, a major subset of pulmonary gammadelta T cells, in host defense against infection with Streptococcus pneumoniae. The proportion and number of whole gammadelta T cells, identified as CD3(+) and TCR-delta(+) cells, and Vgamma4(+) gammadelta T cells, identified as CD3(+) and TCR-Vgamma4(+) cells, increased in the lungs at 3, 6 and 12h post-infection. Survival of infected mice and lung bacterial clearance were severely impaired in TCR-Vgamma4(-/-) mice compared with control wild-type (WT) mice.

View Article and Find Full Text PDF

CD1d-restricted NKT cells are reported to play a critical role in the host defense to pulmonary infection with Pseudomonas aeruginosa. However, the contribution of a major subset expressing a Valpha14-Jalpha18 gene segment remains unclear. In the present study, we re-evaluated the role of NKT cells in the neutrophilic inflammatory responses and host defense to this infection using mice genetically lacking Jalpha18 or CD1d (Jalpha18KO or CD1dKO mice).

View Article and Find Full Text PDF

Interleukin (IL)-12 is a critical cytokine in the T helper (Th)1 response and host defense against intracellular microorganisms, while its role in host resistance to extracellular bacteria remains elusive. In the present study, we elucidated the role of IL-12 in the early-phase host defense against acute pulmonary infection with Streptococcus pneumoniae, a typical extracellular bacterium, using IL-12p40 gene-disrupted (IL-12p40KO) mice. IL-12p40KO mice were highly susceptible to S.

View Article and Find Full Text PDF